ivabradine
NDC 70771-1864, ivabradine, tablet, from Zydus Lifesciences Limited.
- Product NDC
- 70771-1864
- Status
- Listed
- Labeler
- Zydus Lifesciences Limited
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA213442
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1864 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- IVABRADINE HYDROCHLORIDE7.5 mg/1
Pharmacologic classes
Hyperpolarization-activated Cyclic Nucleotide-gated Channel Antagonists [MoA]; Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70771-1864-6 | 70771186406 | 60 TABLET in 1 BOTTLE (70771-1864-6) |
| 70771-1864-8 | 70771186408 | 180 TABLET in 1 BOTTLE (70771-1864-8) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/246b495a-ea7b-4cbe-9a5f-87c2c0a59cb3
Use it
Look up 70771-1864 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1864 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70771-1864. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.